Related by context. All words. (Click for frequent words.) 81 Mouse Model 80 Skeletal Muscle 79 Signaling Pathway 78 Prolongs Survival 78 Allogeneic 78 Modulates 77 Progenitor Cell 77 Immune Responses 77 Adjuvant Chemotherapy 77 Cell Adhesion 77 Peripheral Blood 77 Cell Differentiation 77 Endothelial Cells 77 Hematopoietic 76 Tyrosine Kinase Inhibitor 76 Inhibits 76 Oral Fingolimod 76 Macrophage 76 Epidermal Growth Factor Receptor 76 Clinical Outcome 76 Epithelial 76 Inflammatory Markers 76 Leukemias 76 Tumor Growth 76 Factor Receptor 76 Hematopoietic Stem Cells 76 Mesenchymal Stem Cells 75 Tumor Cells 75 Cell Derived 75 Antigen Specific 75 Protein Linked 75 Endothelial 75 Anti Tumor 75 Tumor Cell 75 Regenerative Cells 75 Tumor Targeting 75 Mouse Models 75 Signaling Pathways 75 Left Ventricular 75 Neural Stem Cells 75 Tumor Suppressor Gene 75 Treating Chronic 75 Inactivation 75 Dehydrogenase 75 Tumor Suppressor 75 Induces 74 Smooth Muscle 74 Cell Transplants 74 Fibroblast 74 Dendritic Cells 74 Lymphoid 74 Oral Cavity 74 Oxidative Stress 74 Chemotherapeutic Agents 74 Improves Outcomes 74 Molecular Mechanism 74 Radiation Induced 74 Subtypes 74 Breast Cancer Cells 74 Myelodysplastic Syndromes 74 Tumor Response 74 Preclinical Study 74 Shows Promise Against 74 Gene Linked 74 Immune Cell 74 Endometrial 74 Mucosal 74 Phosphorylation 74 Patients Receiving 73 Study Evaluating 73 Patients Treated With 73 Hormone Receptor Positive 73 Mimetics 73 Renal Cell Carcinoma 73 Anti Tumor Activity 73 Cerebrospinal Fluid 73 Neuroprotection 73 Cytotoxic T 73 Tumor Progression 73 Genes Linked 73 Glucocorticoid 73 Monoclonal Antibody 73 Elderly Patients 73 Potent Inhibitor 73 Improves Survival 73 Lymphocyte 73 Cancer Cells 73 Genes Involved 73 Fungal Infections 73 Reperfusion Injury 73 Novel Mechanism 73 Estrogen Receptor 73 Improve Survival 73 Slow Progression 73 Protein Involved 73 Coronary Arteries 73 Prognostic Value 73 Protein Synthesis 73 Cytotoxicity 73 Antitumor Activity 73 Angiogenic 73 Adenoma 73 Circulating Tumor Cells 73 Inflammatory Diseases 73 Effective Treatments 73 Meta Analysis 73 Autologous 73 Cutaneous T 73 Amniotic Fluid 73 Septic Shock 73 Test Detects 73 Therapeutic Potential 73 Autologous Stem Cell Transplantation 73 Secondary Hyperparathyroidism 73 Gene Mutation 73 Antithrombin 72 Combination Treatment 72 Immunomodulatory 72 Metastases 72 Systemic Delivery 72 Fibrinogen 72 Carcinomas 72 Tissue Engineered 72 Infarct 72 Novel Oral 72 Polymorphisms 72 Genetic Variation 72 Drug Shows Promise 72 Neoadjuvant Chemotherapy 72 Breast Cancer Metastasis 72 Nerve Cells 72 Cyclooxygenase 2 72 Shows Promising 72 Malignancies 72 Patients Undergoing 72 Advanced Renal Cell 72 Drug Prevents 72 Antitumor 72 Drug Candidate 72 Gene Mutations 72 Ischemic 72 Solid Tumors 72 Preclinical Data 72 Rheumatoid Arthritis Patients 72 Small Intestine 72 Human Neural Stem 72 Proves Effective 72 Malignant Glioma 72 Minimally Invasive Treatment 72 Prophylactic Treatment 72 Recombinant Human 72 Non Invasive Treatment 72 Synaptic Plasticity 72 Novel Small Molecule 72 Critically Ill Patients 72 Cardiac Function 72 Relapsed Refractory 72 Cytotoxic 72 DNA Methylation 72 Allogeneic Stem 72 Secretion 72 MR Angiography 72 Radiofrequency Ablation 72 Renal Function 72 Novel Treatments 72 Knee Osteoarthritis 72 Complicated Skin 72 Immunosuppression 72 Phase 2b Clinical Trial 72 Subunit 72 Attenuates 72 Relapsing Multiple Sclerosis 72 Interferon Beta 72 Demonstrates Efficacy 72 See CLINICAL PHARMACOLOGY 72 Neurogenesis 72 Cell Proliferation 72 Novel Inhibitor 72 Proteasome 72 Germline 72 Appears Safe 72 Gastric Cancer 72 Drug Resistant 71 Hepatocytes 71 Lowers Risk 71 Lymphocytic 71 Transcription Factor 71 Myocardial Ischemia 71 Treatment Reduces 71 RNAi Therapeutic 71 Cognitive Function 71 Inflammatory Response 71 Embryonic Stem Cells 71 Immune Cells 71 Kidney Transplant Recipients 71 Therapeutic Efficacy 71 Localized Prostate Cancer 71 Breast Cancer Stem Cells 71 Epitopes 71 Electrical Stimulation 71 Motility 71 Cancer Stem Cells 71 Contrast Agents 71 Inhibit 71 Phase Ib Clinical Trial 71 Pediatric Patients 71 Unresectable 71 IND Application 71 Kinase Inhibitors 71 Breast Cancer Recurrence 71 Extracellular Matrix 71 Transgenic Mice 71 Long Term Survival 71 complement inhibitor eculizumab 71 Metastatic Colorectal Cancer 71 Monocytes 71 Reductase 71 Kinase Inhibitor 71 Lung Cancers 71 Muscle Wasting 71 Disease Progression 71 Monoclonal 71 Muscle Function 71 Circadian Clock 71 Secretory 71 Leukemia Cells 71 Predict Risk 71 Breast Tumors 71 Androgen Deprivation Therapy 71 Diabetic Neuropathy 71 Gene Variants 71 Multiple Myeloma Patients 71 Stromal 71 Placebo Controlled Study 71 Predict Response 71 Phase 2a Clinical Trial 71 Myeloid 71 Transcriptome 71 Prognostic Factors 71 Multipotent 71 Mitotic 71 Replacement Therapy 71 Node Positive 71 Analytical Tool 71 Soluble CD# 71 Protein Interactions 71 Potent Anti 71 Squamous Cell Carcinoma 71 Beneficial Effects 71 Breast Tissue 71 Conjugated 71 Binding Protein 71 Autoantibodies 71 Hepatocellular Carcinoma 71 Pooled Analysis 71 Effectively Treats 71 TNF Alpha 71 Cardiomyocytes 71 Stem Cell Transplants 71 Heart Failure Patients 71 Bone Metastases 71 Clinical Trial Results 71 Inflammatory Arthritis 71 Bone Marrow Cells 71 Hypertensive Patients 70 Homeostasis 70 Cognitive Impairment 70 Levels Linked 70 Oral Mucositis 70 Transcriptional 70 Subgroup Analysis 70 Antiangiogenic 70 Cell Transplant 70 Impairs 70 Hormone Receptor 70 Antibiotic Resistant 70 Chronic Lymphocytic Leukemia 70 Invasive Fungal Infections 70 Meets Primary Endpoint 70 Prospective Randomized 70 Platelet Derived Growth 70 Immune Mediated 70 Cytochrome P# 70 Kidney Function 70 Ectopic 70 Recurrent Breast Cancer 70 Investigational Agent 70 Targeted Therapy 70 Adjuvant Treatment 70 Molecular Mechanisms 70 Pharmacokinetic Study 70 Receptor Antagonists 70 HDAC Inhibitor 70 Lung Tumors 70 Chemokine Receptor 70 Epithelial Cell 70 Diffuse Large B 70 Inflammatory Pain 70 Placebo Controlled Trial 70 Induces Apoptosis 70 Lymph Node 70 Pre Cancerous 70 Controlled Trial 70 Leukocyte 70 Protein Kinase 70 Growth Hormone Deficiency 70 Abdominal Fat 70 Previously Treated 70 Autoimmune Disease 70 Inhibitory 70 Insulin Sensitivity 70 Contrast Agent 70 Genes Predict 70 J Clin 70 Intravascular 70 Long Term Efficacy 70 Sleep Disturbances 70 Suppresses 70 Phase 2b Trial 70 Molecular Basis 70 Elevated Levels 70 Surgical Treatment 70 Clinical Relevance 70 Autoimmune Diseases 70 Muscle Cells 70 Streptococcus agalactiae 70 Breast Cancers 70 Diagnostic Criteria 70 Hormone Refractory Prostate Cancer 70 Prostatic 70 Initiates Clinical Trial 70 Left Ventricular Hypertrophy 70 Sipuleucel T 70 pDC 70 Malignant Melanoma 70 Castration Resistant Prostate Cancer 70 Vertebral Fractures 70 Neoplasms 70 Metastatic Melanoma 70 Viral Infections 70 Genetic Mutation 70 Advanced Melanoma 70 Prognostic Significance 70 Insulin Resistance 70 Genes Identified 70 Osteoarthritis Patients 70 Genetic Predisposition 70 Decitabine 70 Diabetic Foot Ulcer 70 Postmenopausal Women 70 Clinical Evaluation 70 Neural Stem Cell 70 Blood Vessels 70 Metastatic Prostate Cancer 70 Receptor Signaling 70 Phase 2b Study 70 Fracture Risk 70 Novel Therapeutic 70 murine model 70 Fallopian Tube 70 Pegylated 70 Epidermal 70 Therapeutic Effects 70 Bone Marrow Stem Cells 70 Phase 2a Trial 70 Brain Metastases 70 Adjuvant Therapy 70 Myelofibrosis 70 Diagnostic Tests 70 Neurotrophic Factor 70 Metastatic Cancer 70 Virus Infection 70 Xenograft 70 Oligonucleotides 70 Hypertrophy 70 Chemoradiation 70 Lupus Nephritis 70 AnaSpec Introduces 70 Premature Aging 69 Magnetic Nanoparticles 69 Adenoviral 69 Successfully Treated 69 Holds Promise 69 Intracellular 69 Respiratory Virus 69 Combination Therapy 69 Pulmonary Artery 69 Metabolites 69 Metastatic Renal Cell Carcinoma 69 Immunologic 69 monocytes macrophages 69 Catheter Associated 69 Controlled Study 69 Prostate Cancers 69 Small Molecule 69 Demonstrates Statistically Significant 69 Renal Artery 69 Adjunctive Therapy 69 Peritoneal 69 Unfractionated Heparin 69 Advanced Colorectal Cancer 69 Thrombotic 69 Xenografts 69 Aurora Kinase 69 Oncogenic 69 Infarction 69 Stem Cell Treatment 69 Phosphatase 69 Prostate Tumors 69 Allograft 69 Randomized Study 69 Urinary Incontinence 69 Apoptotic 69 Eukaryotic 69 Antiviral Activity 69 Phospholipase A2 69 Antiviral Therapy 69 Epithelium 69 Antisense Oligonucleotides 69 Antigens 69 Pharmacokinetics PK 69 ORLive Presents 69 Rheumatoid 69 Orally Active 69 von Willebrand Factor 69 Reduces Pain 69 Axonal 69 Therapeutic Antibodies 69 Non Alcoholic Fatty 69 Spinal Fluid 69 Skin Lesions 69 Therapeutic Targets 69 Proliferative 69 Malignancy 69 Chronic HCV 69 Scientists Identify 69 Low Dose 69 Endovascular Treatment 69 Randomized Controlled Trials 69 Herpes Virus 69 Physical Function 69 Induction Therapy 69 Inhaled Corticosteroids 69 C1 Inhibitor 69 Gene Variation 69 Gram Positive 69 Brain Atrophy 69 Reduces Mortality 69 Thyroid Hormone 69 Endothelium 69 Pancreatic Islet 69 Hyperplasia 69 Thrombus 69 Phase IIa Clinical Trial 69 Intracranial Aneurysms 69 Leukemic 69 Menstrual Pain 69 Demonstrates Potential 69 Neuronal 69 Brain Stimulation 69 Gene Variant 69 Is Well Tolerated 69 Prospective Multicenter 69 Acute Ischemic Stroke 69 Mutational 69 P#Y# [001] 69 Present Preclinical Data 69 Therapeutic Antibody 69 Renal Insufficiency 69 Pharmacologic Treatment 69 Protein Expression 69 Lung Cancer Survival 69 Chimeric 69 Diabetic Nephropathy 69 Chemotherapy Induced 69 Researchers Identify 69 Phase IIb Clinical Trial 69 Blood Vessel 69 uricase 69 Treatment Shows Promise 69 Experimental Vaccine 69 Tumor Angiogenesis 69 Study Sheds Light 69 II Clinical Trial 69 Neurodegenerative Disease 69 Atypical Hemolytic Uremic Syndrome 69 Chronic Renal Failure 69 Pluripotent Stem Cells 69 Genotypes 69 Prostate Cancer Patients 69 Genetic Variations 69 Lentiviral 69 Transdermal Delivery 69 Slows Progression 69 Uric Acid 69 Newly Diagnosed Multiple Myeloma 69 Invasive Breast Cancer 69 Iron Overload 69 Liver Tumors 69 #:#-# [023] 69 Soft Tissue Sarcoma 69 Novel Compound 69 Polymerase Inhibitor 69 Squamous 69 Severe Sepsis 69 Metastatic 69 Adult Stem Cell Therapy 68 Patients Suffering 68 Parathyroid Hormone 68 Synthase 68 Inhaled Nitric Oxide 68 Excretion 68 Mammalian 68 Adipose Derived Stem Cells 68 Blood Clotting 68 Parathyroid 68 Clinical Trial Evaluating 68 Epithelial Cells 68 Cognitive Decline 68 Combo Therapy 68 Nicotine Vaccine 68 Embolization 68 Myocardial 68 Preclinical Models 68 Novel Method 68 Dose Response 68 Genes Associated 68 Monocyte 68 Basal Cell 68 Androgen 68 Prolongs Life 68 metastatic neuroendocrine tumors 68 Study Demonstrates 68 Anthracycline 68 Etiology 68 Autoimmune Disorders 68 Dose Ranging Study 68 Cardiotoxicity 68 Immunotherapeutic 68 Histone 68 Novel Therapies 68 Curr Opin 68 Abnormality 68 Situ Hybridization 68 Oropharyngeal 68 Tie2 68 Transmembrane 68 Laryngeal Cancer 68 Iron Deficiency 68 Liver Injury 68 Upregulation 68 Endothelial Function 68 Hematological Cancers 68 Reverse Transcriptase 68 Refractory Hodgkin Lymphoma 68 Shown Effective 68 Disease Modifying 68 Help Detect 68 Proven Effective 68 Successfully Completes Phase 68 Demonstrates Significant 68 Follicular Lymphoma 68 Overactive Bladder 68 Grafts 68 Diabetic Patients 68 Polymorphism 68 Crit Rev 68 Liver Cells 68 Neutrophil 68 Biologic Therapy 68 Treatment Regimen 68 Oncolytic 68 Tumor Necrosis Factor 68 Sevelamer 68 Brain Aneurysms 68 Long Term Outcomes 68 Lymph Nodes 68 Imaging Technique 68 Single Dose 68 Bone Morphogenetic Protein 68 Secretase 68 Virus Linked 68 Chronic Myeloid Leukemia 68 TRAIL receptors 68 downregulates 68 Microtubule 68 Salivary 68 Receives Orphan Drug Designation 68 Quantitation 68 Improved Survival 68 Blood Cancers 68 Increased Mortality 68 Papillary 68 Oocyte 68 Synthetic Peptide 68 Helps Predict 68 Neuroprotective Effects 68 Renal Anemia 68 Chronic Inflammation 68 Interferon Gamma 68 Naive Patients 68 Digestive Tract 68 Treated Patients 68 Risk Stratification 68 Aptamer 68 Epstein Barr Virus EBV 68 Cell Lymphoma 68 Novel Antibiotic 68 Biosynthesis 68 Commonly Used 68 Vascular Grafts 68 Cardiovascular Disease Risk 68 Skin Cells 68 HER2 Positive 68 Hypercholesterolemia 68 Transplant Rejection 68 Incretin 68 Prenatal Diagnosis 68 Lung Injury 68 Cancer Biomarkers 68 Pulmonary Arterial Hypertension 68 Survival Benefit 68 Treatment Naïve Patients 68 Receptor Antagonist 68 Endoplasmic Reticulum 68 Intravesical 68 Therapy Improves 68 CD# + [001] 68 Eculizumab 68 Mutation Analysis 68 Microvascular 68 Anti Angiogenesis 68 Viral Infection 68 Malformations 68 Who Underwent 68 Beta Amyloid 68 Obesity Linked 68 Protein Structure 68 Nerve Cell 68 Protease Inhibitor 68 FDA Approves Drug 68 Study Shows Benefits 68 Randomized Double Blind 68 Detect Cancer 68 Organ Rejection 68 Genetic Variant 68 Randomized Trials 68 Aggressive Prostate Cancer 68 Conjugate 68 Peripheral Arterial 68 Trial Evaluating 68 Egg Freezing 68 Hormonal Therapy 68 Lung Cancer Trial 68 Mammalian Cells 68 Systemic Sclerosis 68 Spinal Fusion 68 Advanced Solid Tumors 68 Radical Prostatectomy 68 Transfection 68 Preterm Delivery 68 Immunomedics Announces 68 B Cell Lymphoma 68 Pancreatic 68 Hematological 68 Calcification 68 Sustained Efficacy 68 Endovascular Repair 68 Radioimmunotherapy 68 Orthostatic Hypotension 68 Total Knee Arthroplasty 68 Newly Diagnosed 68 Severe Asthma 68 FDA Okays 67 RNA Interference 67 Glioma 67 Mesenchymal 67 Innate Immunity 67 Atopic Dermatitis 67 Intravenous Immunoglobulin 67 Hepatitis C Genotype 67 JAK2 enzyme 67 Dendritic Cell 67 Hernia Repair 67 Breast Tumor 67 pulmonary metastases 67 Enzyme Linked 67 Comorbidities 67 Demonstrates Sustained 67 Bacterial Infection 67 CLINICAL PHARMACOLOGY 67 Plus Ribavirin 67 Renal Cancer 67 Systematic Review 67 Initiate Clinical Trial 67 Surgical Procedures 67 Inherited Diseases 67 Phase III Trial 67 Statistically Significant 67 Reduces Risk 67 Hyperlipidemia 67 Genetic Markers 67 Chemoprevention 67 Stenosis 67 Pharmacodynamics 67 ST Segment Elevation 67 Interferon Alfa 67 Therapy Reduces 67 Glucocorticoids 67 CYP#A# CYP#D# 67 Shows Statistically Significant 67 Lowers Blood Pressure 67 exocrine 67 Free Full Text 67 Helps Identify 67 Contrast Enhanced 67 Phase IIb Trial 67 Cellular Immunotherapy 67 Colon Polyps 67 EGFR HER2 67 Anti Inflammatory Drug 67 Infected Patients 67 Node Negative 67 ACE Inhibitors 67 Bevacizumab 67 Advanced Prostate Cancer 67 Improve Outcomes 67 Vaccine Candidate 67 Cannabinoid 67 Antifungal 67 Randomized Double blind 67 Anti Inflammatory Drugs 67 Prodrugs 67 Naturally Occurring 67 ST Elevation Myocardial 67 R lenalidomide 67 Cocaine Addiction 67 Therapeutic Agents 67 extracellular signal 67 Chronic Heart Failure 67 Valve Replacement 67 #:#-# [035] 67 Treatment Naive Patients 67 Could Detect 67 Vitro Activity 67 REMINDER ORLive Presents 67 Image Guided 67 Placental 67 Less Invasive 67 Hepatic 67 Myoblast 67 Electroporation 67 Neovascular Age Related Macular 67 #-# Full Text 67 Catheter Ablation 67 Neurotransmitter 67 Completes Patient Enrollment 67 Beta Blocker 67 Resection 67 Retinoic Acid 67 TNF Blockers 67 Multidrug Resistant 67 Glycosylation 67 Clinical Trial Data 67 Lower Extremity 67 Coronary Angiography 67 poly ADP ribose polymerase 67 Premenopausal Women 67 bFGF 67 mediated inhibition 67 Portal Hypertension 67 Membrane Proteins 67 Occlusion 67 T Lymphocyte 67 Functional Outcomes 67 Advanced Ovarian Cancer 67 Hepatocellular 67 Brain Cells 67 familial amyloidotic polyneuropathy FAP 67 Brain Tumors 67 Data Suggest 67 essential thrombocythemia ET 67 Colorectal Adenomas 67 RNAi Therapeutics 67 Stomach Cancer 67 Receptor Agonist 67 Combination REOLYSIN R 67 BiTE Antibody 67 Radiation Dose 67 Physiology Seminar 67 Androgen Receptor 67 Oral Formulation 67 FDA Approvals 67 Valvular 67 Protein Kinase Inhibitors 67 cisplatin resistant 67 Stress Induced 67 CT Angiography 67 Metabolic Disorder 67 Protein Kinase C 67 Vaccine Protects Against 67 Hepatocyte 67 Thromboembolism 67 Transdermal Patch 67 Venous Thrombosis 67 Amyloid 67 Differentially 67 Inhibits Growth 67 Bioavailability 67 Pivotal Trial 67 Findings Suggest 67 Ovarian Cancer Patients 67 #:#-# [033] 67 Microalbuminuria 67 Multicenter Trial 67 Investigational Treatment 67 #:#-# [037] 67 Refractory Angina 67 hepatoma 67 Methylnaltrexone 67 Recombinant Protein 67 Sirolimus Eluting Stent 67 Solid Tumor 67 Glycoprotein 67 retinal ischemia 67 Immunosuppressive 67 Lymphocytes 67 matrix metalloproteases 67 Ultrasound Guided 67 Relapsing Remitting Multiple Sclerosis 67 interleukin IL -# 67 Stakeholder Opinions 67 Hepatitis C Virus Infection 67 Antisense Drug 67 Novel Protein 67 Ovarian Cancers 67 Imaging Techniques 67 Stromal Cells 67 Differential Diagnosis 67 Demonstrate Significant 67 Liver Metastases 67 Shows Efficacy 67 Randomized Controlled Trial 67 FASEB J. 67 Bloodstream Infections 67 Reprogrammed 67 Cancer Recurrence 67 Intracranial 67 Cholinesterase Inhibitors 67 Pluripotency 67 Antibody Therapy 67 Hemolysis 67 Anticancer Drugs 67 Anticancer Activity 67 Study Casts Doubt 67 OCT4 67 Predict Breast Cancer 67 Hepatitis B Virus 67 Universal Flu Vaccine 67 Clinical Efficacy 67 Derived Factor 67 Chronic Pelvic Pain 67 Skin Cancers 67 Chemotherapy Improves 67 Tyrosine Kinase Inhibitors 67 Pathogen Detection 67 Phenotypes 67 Nucleoside 67 Mental Decline 67 Cardiovascular Outcomes 67 Mol Cell 67 Conjugates 67 Prostate Cancer Treatment 67 Taxane 67 Alveolar 67 First Patient Dosed 67 Hsp# Inhibitor 67 Potentially Fatal 67 Fibrosis 67 J Am Acad 67 Pegylated Liposomal Doxorubicin 67 Drug Combo 67 K ras mutations 67 Lung Cancer Patients 67 Epileptic Seizures 67 Thoracic Aortic Aneurysms 67 Atypical Antipsychotic 67 underlying vasculopathy 67 Granulocyte Colony Stimulating Factor 67 Mitochondrial Dysfunction 67 Novel Approach 66 CYT# potent vascular disrupting 66 Nuclear Receptor 66 Antiplatelet 66 Anthrax Toxin 66 Targeted Therapies 66 Mutagenesis 66 Stent Placement 66 Liver Failure 66 Inflammatory Disease 66 Intracerebral Hemorrhage 66 Vaccine Shows Promise 66 Male Infertility 66 Carotid Endarterectomy 66 Dose Escalation 66 Renal Impairment 66 Synovial 66 doi #.#/fj.#-# 66 leiomyomas 66 Progressive Multifocal Leukoencephalopathy 66 Viral Load 66 Serious Infections 66 Randomized Phase 66 Blood Pressure Drug 66 Eur J 66 Hedgehog Pathway 66 Prodrug 66 Reduced Risk 66 Induced Pluripotent Stem Cells 66 Skin Disorders 66 Urinary Tract Infections 66 Histologic 66 Urine Test 66 Pregnancy Linked 66 Chronic Sinusitis 66 Disease Causing 66 Nat Clin Pract 66 Contralateral 66 Myelination 66 Combination Clinical Trial 66 Fecal Incontinence 66 Files IND 66 HEK# 66 Topical Treatment 66 Carotid Stenting 66 Enlarged Prostate 66 Innate Immune 66 Ultrasensitive 66 androgen receptor AR 66 Postdoctoral Position 66 Kidney Transplant Patients 66 chronic eosinophilic leukemia 66 Chronic Liver Disease 66 Meningiomas 66 Demonstrates Potent 66 HCV Infection 66 Activator CK # 66 Proc Am Soc 66 Neoplastic 66 Blood Flow 66 small molecule activator 66 Device Helps 66 Oncolytic Reovirus 66 Brain Wiring 66 Prostate Biopsy 66 Study Shows Promise 66 Protein Biomarker 66 Gene Silencing 66 Sapacitabine 66 Hypoxia Inducible Factor 66 Adipose Tissue 66 Colorectal Cancers 66 Corneal Transplant 66 Antiviral Drugs 66 Testis 66 Urinary Catheter 66 Phase III Clinical Trial 66 Help Predict 66 Tissue Samples 66 Extracellular 66 Biomarker Study 66 Diagnosis Treatment 66 Patients Treated 66 Assay Kits 66 5 Fluorouracil 66 Sex Hormones 66 Lung Tumor 66 Beta Blockers 66 Anticancer Drug 66 clonogenic 66 Tumor Markers 66 Dry Powder Inhalers 66 Pegylated Interferon 66 Treat Anemia 66 Gastrointestinal Disorders 66 Nucleic Acids 66 Systolic Blood Pressure 66 Often Misdiagnosed 66 Transplant Patients 66 #:#-# [031] 66 J Am Soc 66 Advanced Pancreatic Cancer 66 Double Blind Randomized 66 Chronic Bronchitis 66 Confirmatory Phase 66 Antiplatelet Therapy 66 Wound Dressings 66 Parthenogenetic 66 Treatment Naïve